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support this hypothesis, and no good evi-
dence that specific treatment by allergen avoidance
therapy (or even non-specific treatment with conti
corticosteroids) can preve t acute infectious sinus
who do not have underlying chronic sinusitis. Mo
acute sinusitis are sequelae to viral upper respirato
tions. However, topical corticosteroids are an effectoe
tio
sinD s allergy predispose to acute infec-us sinusitis? Some patients reportus infections during the hayfever
season, and it is commonly supposed that
congestion associated with allergic rhinitis
can predispose to infectious sinusitis by
interfering with the function of the sinus







antibiotic therapy in cases of acute infectious sinusitis, with or
without coexisting allergy (Level II).1
Does allergy cause chronic rhinosinusitis or nasal polyposis?
Chronic rhinosinusitis (CRS) (ie, inflammation of the mucosa of the
nose and the paranasal sinuses) can be subdivided into two types
according to the presence or absence of nasal polyposis (NP).2 The
mucosal inflammation in CRS without polyposis is usually neu-
trophil predominant, but when NP is present (CRS/NP) it is usually
eosinophil predominant. The tissue eosinophilia and frequent asso-
ciation of CRS/NP with asthma3 have led to the assumption that
CRS/NP is caused by allergy. However, most studies have shown that
the presence of IgE to environmental allergens (atopy) is no more
common in people with CRS (with or without NP) than in the
general population, and the symptoms of CRS are not affected by
seasonal changes or allergen exposure. Thus it is now thought that
allergy is not the cause of CRS in most cases. Atopy may coexist with
CRS, and symptoms of allergic rhinitis can be superimposed on
symptoms of CRS. There is no evidence that allergen avoidance or
immunotherapy can alleviate CRS, but it may relieve superimposed
hayfever symptoms.
A subset of CRS/NP associated with chronic fungal infection and
systemic fungal allergy has been termed “allergic fungal sinusitis”,
but the exact parameters of this entity remain unclear. Antifungal
treatments have been disappointing, and the evidence for effective-
ness of immunotherapy for fungal allergy in this condition is limited.
In most cases, the cause of CRS is not apparent. Bacterial infection
frequently coexists, but may not be causative. Current theories of
causation include bacterial biofilms, fungal hypersensitivity, sensitiv-
ity to bacterial superantigens, and genetic factors.
What is the relationship between aspirin sensitivity and sinus
disease? About a third of adults with CRS/NP and asthma also have
aspirin sensitivity, in which the ingestion of aspirin or another non-
steroidal anti-inflammatory drug (NSAID) causes an acute exacerba-
tion of asthma or nasal symptoms or both. This is not an IgE-
mediated allergy, but rather a pharmacological intolerance due to
dysregulation of prostaglandin and leukotriene metabolism. Patients
with CRS may also note symptom exacerbation after intake of
alcohol or sulphites, or from aeroirritants such as smoke and fumes.
Because these are not true allergies, skin prick testing and allergen
desensitisation are not applicable. Aspirin desensitisation by graded
oral doses can be effective, but must only be
carried out by a specialist under controlled,
supervised conditions.
Investigation and referral. CRS can cause
symptoms similar to perennial allergic rhini-
tis, and may be indistinguishable on history
alone. Anosmia and the presence of nasal
polyps seen on anterior rhinoscopy (Figure)
are good predictors of chronic sinusitis. How-
ever, the complaint of “sinus headache” is not a good predictor of a
radiographic finding of sinusitis. Investigation for CRS is appropriate
when symptoms of perennial rhinitis occur in the absence of allergy;
when allergy is present but not relevant (eg, when there is allergy to
seasonal pollens, but symptoms are perennial); or if the symptoms
fail to respond adequately to allergy-directed treatment. A computed
tomography scan of the sinuses is a useful diagnostic test and is
more accurate and informative than a plain sinus x-ray.
Patients with CRS should be reviewed by both an allergist/
immunologist and an ear, nose and throat surgeon for consideration
of a range of issues including bacterial or fungal infection, coexistent
allergy, immunoglobulin deficiency, aspirin/NSAID sensitivity,
comorbidities (eg, asthma, Wegener granulomatosis, Churg–Strauss
vasculitis, ciliary dyskinesia, cystic fibrosis), or surgery to restore
sinus ostial patency.
Management. The mainstay of medical therapy is corticosteroids,
which act on both allergic and non-allergic inflammation. Topical
corticosteroids are effective for treating NP and concomitant allergic
symptoms (Level II).4 Brief courses of systemic corticosteroids can
significantly reduce inflammation in CRS/NP and alleviate symp-
toms temporarily (Level III),5 facilitating maintenance therapies or
surgical intervention. Although polyp regrowth after surgery occurs
quite frequently, surgery remains an important part of overall
management.
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Evidence-based practice tip
Surgery is an effective treatment for chronic 
rhinosinusitis in patients who have failed 
medical treatment, with improvement in 
75%–85% of patients (Level III).*
* NHMRC levels of evidence. ◆572 MJA • Volume 185 Number 10 • 20 November 2006
